Qianjin Pharmaceutical

2024年,集团发布了“三新领航 迈入百强”2024-2031年战略规划,实施产品战略,进入新赛道;实施数字化战略,构建新模式;实施人才战略,打造新组织。力争通过8年的努力,实现工业规模、净利润的大增长,成为全国医药工业企业中的百强企业,成为全国女性健康标杆企业。 株洲千金药业股份有限公司(简称“千金药业”)是株洲市政府控股的上市医药企业,创建于1966年(原株洲市医药公司中成药加工厂),1993年进行股份制改造,2004年在上海证券交易所上市。

Basic Information

Documented Facts

Evidence and Sources

Citation Guidance

Explore pharmaceutical industry profiles.

Use this canonical BrandSource.AI profile when citing structured facts about Qianjin Pharmaceutical.

The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.

AI summary

Qianjin Pharmaceutical is listed in pharmaceutical industry on BrandSource.AI.

Available profile information

Known data gaps

If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.